カテゴリ： GlobalData, 企業調査, 日本

Sysmex Corp (6869)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Sysmex Corp (6869) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C11393
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：88
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Sysmex Corp (6869) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Sysmex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Sysmex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Sysmex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Sysmex Corp, Medical Equipment, Deal Details 13
Partnerships 13
Sysmex Enters into Licensing Agreement with Human Metabolome Technologies 13
Sysmex Enters Into Licensing Agreement With Merck Millipore 14
Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio 15
Sysmex, Foundation for Biomedical Research and Kyoto University Enter into Joint Research Agreement 16
JVCKENWOOD to Form Joint Venture with Sysmex 17
genedrive Enters into Distribution Agreement with Sysmex Asia Pacific 18
genedrive Enters into Distribution Agreement with Sysmex Europe 19
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 20
Sysmex Partners with Clearbridge BioMedics 21
Sysmex Inostics Enters into Distribution Agreement with Streck 22
Sysmex America Enters into Distribution Agreement with Medline Industries 23
Eisai Enters into Agreement with Sysmex 24
Sysmex Enters into Co-Development Agreement with LabCorp 25
Sysmex Inostics Enters into Distribution Agreement with IndivuTest 26
Sysmex and Toppan Printing to Collaborate in Genetic Analysis Testing Industry 27
Sysmex America Enters Into Distribution Agreement With Henry Schein For Hematology Analyzers 28
Sysmex America Enters Into Agreement With Software Testing Solutions 29
National Cancer Center Enters into Co-Development Agreement with Sysmex 30
Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare 31
Sysmex America Extends Distribution Agreement With Medica For EasyCell Assistant 32
Endomagnetics Enters Into Distribution Agreement With Sysmex Europe 33
Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 34
Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 35
Sysmex Extends Distribution Agreement With Roche 36
Asset Transactions 37
Windsor Regional Hospital Acquires Sysmex XN-Series Hematology Analyzers From Sysmex Canada 37
Acquisition 38
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 38
Sysmex Acquires Oxford Gene Technology 39
Sysmex Acquires Partec 40
Sysmex Completes Acquisition of Inostics from Indivumed 41
Sysmex Rumored To Acquire Dune Medical Devices For US$200 Million 43
Sysmex Corp – Key Competitors 44
Sysmex Corp – Key Employees 45
Sysmex Corp – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Joint Venture 49
Recent Developments 50
Strategy And Business Planning 50
Nov 08, 2018: OGT further expands global direct sales and support into Asia-Pacific 50
Aug 03, 2018: Sysmex and JVCKENWOOD jointly establish company to use micro and nano-fabrication technology to develop and manufacture IVD Biodevices 51
Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 53
May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 54
May 08, 2018: Sysmex to Establish Bio-Diagnostic Reagent Center 56
Dec 11, 2017: Sysmex to Commence OncoBEAM Lab Assay Services (for Research) in Japan, as well as in Germany and the United States, to Analyze Genetic Mutations Related to Circulating Tumor DNA 57
Jun 01, 2017: Sysmex Opens New RD Facility with a View toward the Realization of Personalized Medicine 59
Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 60
Financial Announcements 61
Aug 03, 2018: Sysmex: Summary of consolidated financial results for the first three months of the fiscal year ending March 31, 2019 61
May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 66
Feb 06, 2018: Sysmex: Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018 69
Corporate Communications 71
Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes 71
Sep 13, 2017: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year 73
Legal and Regulatory 74
Apr 24, 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers 74
Jan 18, 2018: Sysmex Harmony Wins Certification as Special Subsidiary Company 76
Product News 77
Mar 29, 2018: Sysmex to Launch the Automated High-sensitive Immunoassay System for Research Applications HI-1000 77
Oct 12, 2017: Sysmex: Insurance Coverage of Lymph Node Metastasis Testing for Non-Small-Cell Lung Cancer Using the OSNA Method 78
Sep 26, 2017: Sysmex Launches the Revohem FVIII Chromogenic, a Coagulation Factor VIII Assay Reagent 79
Other Significant Developments 80
Jul 02, 2018: OGT expands direct sales and support infrastructure in Europe 80
Apr 05, 2018: Sysmex Launches Caresphere a New Network Solution 81
Apr 04, 2018: Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors 83
Sep 19, 2017: Sysmex Signs Agreement with Mongolia’s Ministry of Health to Provide External Quality Assessment Support in the Field of Blood Morphology Testing 84
Sep 05, 2017: Sysmex Begins Conducting Direct Sales and Services in Ghana 86
May 21, 2017: Sysmex New Zealand Commence Direct Sales of Urinalysis Instrument Portfolio 87
Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88

List of Tables
Sysmex Corp, Medical Equipment, Key Facts, 2018 2
Sysmex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Sysmex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Sysmex Corp, Deals By Market, 2012 to YTD 2018 10
Sysmex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Sysmex Enters into Licensing Agreement with Human Metabolome Technologies 13
Sysmex Enters Into Licensing Agreement With Merck Millipore 14
Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio 15
Sysmex, Foundation for Biomedical Research and Kyoto University Enter into Joint Research Agreement 16
JVCKENWOOD to Form Joint Venture with Sysmex 17
genedrive Enters into Distribution Agreement with Sysmex Asia Pacific 18
genedrive Enters into Distribution Agreement with Sysmex Europe 19
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 20
Sysmex Partners with Clearbridge BioMedics 21
Sysmex Inostics Enters into Distribution Agreement with Streck 22
Sysmex America Enters into Distribution Agreement with Medline Industries 23
Eisai Enters into Agreement with Sysmex 24
Sysmex Enters into Co-Development Agreement with LabCorp 25
Sysmex Inostics Enters into Distribution Agreement with IndivuTest 26
Sysmex and Toppan Printing to Collaborate in Genetic Analysis Testing Industry 27
Sysmex America Enters Into Distribution Agreement With Henry Schein For Hematology Analyzers 28
Sysmex America Enters Into Agreement With Software Testing Solutions 29
National Cancer Center Enters into Co-Development Agreement with Sysmex 30
Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare 31
Sysmex America Extends Distribution Agreement With Medica For EasyCell Assistant 32
Endomagnetics Enters Into Distribution Agreement With Sysmex Europe 33
Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 34
Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 35
Sysmex Extends Distribution Agreement With Roche 36
Windsor Regional Hospital Acquires Sysmex XN-Series Hematology Analyzers From Sysmex Canada 37
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 38
Sysmex Acquires Oxford Gene Technology 39
Sysmex Acquires Partec 40
Sysmex Completes Acquisition of Inostics from Indivumed 41
Sysmex Rumored To Acquire Dune Medical Devices For US$200 Million 43
Sysmex Corp, Key Competitors 44
Sysmex Corp, Key Employees 45
Sysmex Corp, Other Locations 46
Sysmex Corp, Subsidiaries 47
Sysmex Corp, Joint Venture 49

List of Figures
Sysmex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sysmex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Sysmex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Sysmex Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Sysmex Corp (6869)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Cara Therapeutics Inc (CARA)-医療機器分野：企業M&A・提携分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a clinical-stage biotechnology company that develops novel therapeutics for pain and inflammation and pruritus. The company products include kappa receptor agonists and cannabinoid receptors. It offers products for therapeutic areas which include …
  • Immatics Biotechnologies GmbH：企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Denka Company Ltd：企業の戦略・SWOT・財務分析
    Denka Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Denka Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BoneSupport AB：企業の製品パイプライン分析
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; diseas …
  • Myriad Group AG：企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Linn Energy, LLC：企業の戦略・SWOT・財務情報
    Linn Energy, LLC - Strategy, SWOT and Corporate Finance Report Summary Linn Energy, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CIBC Wealth Management：企業の戦略・SWOT・財務分析
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Eguana Technologies Inc. (EGT)：電力：M&Aディール及び事業提携情報
    Summary Eguana Technologies Inc. (Eguana), formerly Sustainable Energy Technologies Ltd, is a power electronics company that designs, manufactures and supplies high performance power control solutions for grid interactive energy storage systems. The company’s power control solutions charge and disch …
  • Argon Medical Devices Inc：医療機器：M&Aディール及び事業提携情報
    Summary Argon Medical Devices Inc (Argon) is a medical device company that manufactures and supplies products for the dialysis and others. The company provides arterial catheters, temporary pacing electrode trays, pulmonary artery and thermodilution catheters, and single lumen central venous cathete …
  • Moximed Inc：医療機器：M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • SilverSun Technologies Inc (SSNT)：企業の財務・戦略的SWOT分析
    Summary SilverSun Technologies Inc (SilverSun) is a technology company that offers transformational business technology solutions and services for manufacturers and distributors. The company’s ERP software products comprise ERP X3, MAS90 and MAS200. It offers network services such as 24/7 remote net …
  • CF Industries Holdings Inc (CF)：企業の財務・戦略的SWOT分析
    CF Industries Holdings Inc (CF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Azure Power India Private Limited (AZRE)-エネルギー分野：企業M&A・提携分析
    Summary Azure Power India Private Limited (Azure) is a renewable energy company that offers solar products. The company designs, installs, produces, finances, owns and operates solar power plants. Its services include engineering, operational performance monitoring, and others. Azure provides off gr …
  • Investors Heritage Capital Corporation：企業の戦略・SWOT・財務情報
    Investors Heritage Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Investors Heritage Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Karelia Tobacco Company Inc SA：企業の戦略・SWOT・財務情報
    Karelia Tobacco Company Inc SA - Strategy, SWOT and Corporate Finance Report Summary Karelia Tobacco Company Inc SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Partners Group Holding AG (PGHN)：企業の財務・戦略的SWOT分析
    Summary Partners Group Holding AG (Partners Group) is a private market investment manager that offers private equity and investment services. The company manages investment programs and customized portfolios for institutional investors such as insurance companies, pension funds, and sovereign wealth …
  • Intellia Therapeutics Inc (NTLA)：企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Psychemedics Corp (PMD)：企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) provides clinical laboratory services. The company provides testing for drugs abuse using hair analysis. It also offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzo …
  • Pon Holdings BV：企業の戦略・SWOT・財務情報
    Pon Holdings BV - Strategy, SWOT and Corporate Finance Report Summary Pon Holdings BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Caleres Inc (CAL)：企業の財務・戦略的SWOT分析
    Caleres Inc (CAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆